Jeremy Yarwood, an officer at Neogen Corp, has sold 9,051 shares of common stock, valued at approximately $114,637. This sale occurred on November 4, 2026, following the vesting of restricted stock.

Neogen Corp, a company involved in the life sciences sector, focuses on in vitro and in vivo diagnostic substances. According to the recent SEC filing, the shares were sold through Fidelity Brokerage Services LLC.

The filing indicates that Yarwood acquired the shares on November 1, 2026, as part of a compensation package. The transaction reflects Yarwood's ongoing relationship with Neogen Corp as an officer of the company.

The sale of these shares may influence the perception of Neogen Corp's management and their confidence in the company's future. With 218,306,034 shares outstanding, this transaction represents a small fraction of the total equity.

Details were not available in the SEC filing regarding any future plans or additional transactions related to this sale.

Transaction Details

The shares sold by Jeremy Yarwood were part of a restricted stock vesting transaction, indicating that they were acquired as part of his compensation package from Neogen Corp. The acquisition date for these shares was November 1, 2026, which is just a few days prior to the sale.

The filing specifies that the shares were sold through Fidelity Brokerage Services LLC, located in Smithfield, Rhode Island. This brokerage acted as the intermediary in the transaction.

Regulatory Context

This Form 144 filing is a notification to the SEC regarding the sale of restricted securities, which allows the holder to sell shares in a public offering under certain conditions. The filing also indicates that there were no other securities sold by Yarwood in the past three months, highlighting that this transaction was a singular event in that timeframe.

"The filing serves as a formal declaration of Yarwood's intention to sell shares that were acquired through his role at Neogen Corp, ensuring compliance with SEC regulations regarding insider transactions."

Company Information

Neogen Corp is incorporated in Michigan and operates under the Standard Industrial Classification of In Vitro & In Vivo Diagnostic Substances. The company has a fiscal year that ends on May 31, and its business address is also located at 620 Lesher Place, Lansing, MI.

The filing does not include any information about Yarwood's total holdings after this sale or any potential plans for future transactions involving Neogen Corp's stock.